Key result
Repeated levosimendan linked to improved cardiac index of 2.5 L/min/m² in postcardiotomy cardiogenic shock.
Why the study?
Postcardiotomy cardiogenic shock after CABG is life-threatening, and criteria for repeated levosimendan administration in this setting are not well defined.
Does repeated levosimendan administration improve hemodynamics in a patient with postcardiotomy cardiogenic shock after CABG?
Case Report (n=1)
No
Does repeated levosimendan administration improve hemodynamics in a patient with postcardiotomy cardiogenic shock after CABG?
Repeated levosimendan administration guided by invasive hemodynamics may be associated with hemodynamic improvement in postcardiotomy cardiogenic shock.
Answers are grounded in this paper and cite their sources.
Hemodynamic improvement in this single case should not change practice; leaves open the role of repeated levosimendan guided by invasive monitoring in postcardiotomy shock.
Postcardiotomy cardiogenic shock is a life-threatening complication after coronary artery bypass grafting (CABG), especially in patients with severely impaired left ventricular systolic function. Management remains challenging, and criteria for repeated levosimendan administration in this setting are not well defined. We report the case of a 74-year-old man with ischemic cardiomyopathy and severely reduced preoperative left ventricular ejection fraction who underwent preoperative levosimendan optimization followed by off-pump CABG. Despite initial improvement, the patient developed postcardiotomy cardiogenic shock in the early postoperative period with progressive hypoperfusion, lactate elevation, worsening ventricular dysfunction, and a low cardiac index confirmed by Swan-Ganz catheterization. Intra-aortic balloon pump support was initiated in the early postoperative period, and norepinephrine was the only vasoactive agent used before repeated levosimendan administration. Because of persistent low-output physiology, invasive hemodynamic findings, and a previously favorable response to levosimendan, repeated levosimendan infusion was administered. Subsequent reassessment showed improvement in cardiac index, filling pressures, vascular resistance, ventricular function, and biochemical markers of hypoperfusion and organ dysfunction. This case illustrates that repeated levosimendan administration, guided by invasive hemodynamic assessment, was associated with hemodynamic improvement in postcardiotomy cardiogenic shock after CABG. These findings are hypothesis-generating and should be interpreted with caution. Further prospective studies are required to define patient selection criteria, optimal timing, and the role of repeated levosimendan administration in this setting.
No takes yet. Share an insight, caveat, or question.
Kuntsevich et al. (2026) conducted a case report in Postcardiotomy cardiogenic shock (n=1). Repeated levosimendan administration was evaluated on Hemodynamic improvement (cardiac index, pulmonary capillary wedge pressure, systemic vascular resistance). Repeated levosimendan administration guided by invasive hemodynamic assessment was associated with hemodynamic improvement, including an increase in cardiac index to 2.5 L/min/m², in a patient with postcardiotomy cardiogenic shock.
Synapse has enriched 10 related papers. Consider them for comparative context: